首页 > 最新文献

Journal of Advanced Pharmaceutical Technology & Research最新文献

英文 中文
Efficacy of a Eucalyptus oil-based dentifrice in reducing plaque and gingival bleeding scores - A randomized clinical crossover study. 以桉树油为基础的牙膏在减少牙菌斑和牙龈出血评分方面的功效--一项随机临床交叉研究。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.4103/JAPTR.JAPTR_103_23
Fatema Alzahraa Osman, Leen Abdulghani Sarhan, Nirmeen Elhussein Eladl, Vijay Desai, Jayaraj Narayanan, Lakshmi Thangavelu, Sudhir Rama Varma

Herbal products in dentistry have grown significantly. In the current scenario, herbal products are believed to be an effective adjunct to other medications. The present study aims to evaluate Eucalyptus oil and miswak (Salvadora persica) toothpaste for its efficacy in observable reduction in plaque and gingival bleeding. Sixty participants with gingivitis were enrolled in the present study. The study included an interim period (washout) comparing miswak and Eucalyptus toothpaste. Plaque scores were measured at designated time intervals. Both herbal toothpastes significantly decreased plaque index. Nevertheless, with relation to miswak (P = 0.002), Eucalyptus oil-based toothpaste exhibited reduction in bleeding scores. When participants were asked to return to their routine toothpaste, no changes were observed. Results from the study showed that the toothpaste containing Eucalyptus showed a significant decrease in gingival bleeding. More investigations should be looked on the medicinal applications of Eucalyptus toothpaste on commonly seen periodontal parameters.

牙科中的草药产品有了长足的发展。目前,草药产品被认为是其他药物的有效辅助手段。本研究旨在评估桉树油和miswak(Salvadora persica)牙膏在明显减少牙菌斑和牙龈出血方面的功效。本研究共招募了 60 名牙龈炎患者。研究包括一个比较 miswak 牙膏和桉树牙膏的过渡期(冲洗期)。在指定时间间隔测量牙菌斑评分。两种草药牙膏都能明显降低牙菌斑指数。然而,与miswak相比(P = 0.002),桉树油牙膏的出血评分有所下降。当要求参与者重新使用常规牙膏时,没有观察到任何变化。研究结果表明,含桉树油的牙膏能显著减少牙龈出血。应进一步研究桉树牙膏对常见牙周参数的药用效果。
{"title":"Efficacy of a <i>Eucalyptus</i> oil-based dentifrice in reducing plaque and gingival bleeding scores - A randomized clinical crossover study.","authors":"Fatema Alzahraa Osman, Leen Abdulghani Sarhan, Nirmeen Elhussein Eladl, Vijay Desai, Jayaraj Narayanan, Lakshmi Thangavelu, Sudhir Rama Varma","doi":"10.4103/JAPTR.JAPTR_103_23","DOIUrl":"10.4103/JAPTR.JAPTR_103_23","url":null,"abstract":"<p><p>Herbal products in dentistry have grown significantly. In the current scenario, herbal products are believed to be an effective adjunct to other medications. The present study aims to evaluate <i>Eucalyptus</i> oil and miswak (Salvadora persica) toothpaste for its efficacy in observable reduction in plaque and gingival bleeding. Sixty participants with gingivitis were enrolled in the present study. The study included an interim period (washout) comparing miswak and <i>Eucalyptus</i> toothpaste. Plaque scores were measured at designated time intervals. Both herbal toothpastes significantly decreased plaque index. Nevertheless, with relation to miswak (<i>P</i> = 0.002), <i>Eucalyptus</i> oil-based toothpaste exhibited reduction in bleeding scores. When participants were asked to return to their routine toothpaste, no changes were observed. Results from the study showed that the toothpaste containing <i>Eucalyptus</i> showed a significant decrease in gingival bleeding. More investigations should be looked on the medicinal applications of <i>Eucalyptus</i> toothpaste on commonly seen periodontal parameters.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"15 1","pages":"25-28"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Test of insulin resistance in nondiabetic and streptozotocin-induced diabetic rats using glycosylated hemoglobin test and other interventions. 利用糖化血红蛋白测试和其他干预措施测试非糖尿病大鼠和链脲佐菌素诱导的糖尿病大鼠的胰岛素抵抗。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.4103/JAPTR.JAPTR_343_23
Lina AlTamimi, Zainab Z Zakaraya, Mohammad Hailat, Mousa N Ahmad, Nidal A Qinna, Mohammed F Hamad, Wael Abu Dayyih

Type 2 diabetes is common globally. Pioglitazone (PGZ) is an oral TZD antidiabetic, whereas chromium-picolinate (Cr-PL) and Cr-glucose tolerance factor (Cr-GTF) are useful type 2 diabetes mellitus (T2DM) supplements. Cr-PL/GTF antioxidants cure T2DM. They may fail in diabetes with or without insulin-sensitizing medications. It examined how Cr-PL, Cr-GTF, PGZ, and their combination affected glucose, glycosylated hemoglobin, insulin, and HOMA-IR. Sixty-three adult Sprague-Dawley rats (220-300 g) were selected, and nine rats were randomly assigned to a normal nondiabetic group. In contrast, 54 rats were randomly split into 9 rats per each of the 6 major groups and injected intraperitoneally with 40 mg/kg STZ to induce T2DM. Rats were administered PGZ = 0.65 mg/kg (rat weight)/day, Cr-PL = 1 mg/kg, Cr-GTF = 1 mg/kg, and their combinations (PGZ + Cr-PL and Cr-GTF) daily for 6 weeks per intervention. The PGZ + Cr-PL and PGZ + Cr-GTF groups had substantially lower insulin levels than the PGZ group (13.38 ± 0.06, 12.98 ± 0.19 vs. 14.11 ± 0.02, respectively), with the PGZ + Cr-GTF group having the lowest insulin levels (12.98 ± 0.19 vs. 14.11 ± 0.02, 13.38±0.06, respectively). Intervention substantially reduced HOMA-IR in the PZ + Cr-PL and PZ + Cr-GTF groups compared to PGZ (7.49 ± 0.04, 6.69 ± 0.11 vs. 8.37 ± 0.04, respectively). This research found that combining PGZ with Cr-GTF resulted in considerably lower HOMA-IR levels than the PGZ and Cr-PL groups (6.69 ± 0.11 vs. 8.37 ± 0.04, 7.49 ± 0.04, respectively). Both Cr-PL and Cr-GTF may control T2DM. Both Cr complexes improved T2DM biomarkers more than the control diabetic group without medication. PGZ alone and PGZ + Cr-PL had less pharmacological synergy than Cr-GTF and PGZ in altering insulin and HOMA-IR blood levels. These encouraging discoveries need more study.

2 型糖尿病在全球很常见。吡格列酮(PGZ)是一种口服 TZD 抗糖尿病药物,而吡啶甲酸铬(Cr-PL)和葡萄糖耐量因子(Cr-GTF)则是有效的 2 型糖尿病(T2DM)补充剂。铬吡啶/葡萄糖耐量因子抗氧化剂可治疗 T2DM。在糖尿病患者服用或不服用胰岛素增敏药物的情况下,它们可能会失效。该研究考察了 Cr-PL、Cr-GTF、PGZ 及其组合对血糖、糖化血红蛋白、胰岛素和 HOMA-IR 的影响。研究人员挑选了 63 只成年 Sprague-Dawley 大鼠(220-300 克),其中 9 只被随机分配到正常非糖尿病组。54只大鼠被随机分成6大组,每组9只,腹腔注射40毫克/千克STZ诱导T2DM。每天给大鼠注射 PGZ = 0.65 毫克/千克(大鼠体重)/天、Cr-PL = 1 毫克/千克、Cr-GTF = 1 毫克/千克以及它们的组合(PGZ + Cr-PL 和 Cr-GTF),每次干预 6 周。PGZ+Cr-PL组和PGZ+Cr-GTF组的胰岛素水平大大低于PGZ组(分别为13.38±0.06、12.98±0.19 vs. 14.11±0.02),其中PGZ+Cr-GTF组的胰岛素水平最低(分别为12.98±0.19 vs. 14.11±0.02、13.38±0.06)。与 PGZ 组相比,PZ + Cr-PL 组和 PZ + Cr-GTF 组的 HOMA-IR 干预显著降低(分别为 7.49 ± 0.04、6.69 ± 0.11 vs. 8.37 ± 0.04)。该研究发现,PGZ 与 Cr-GTF 组的 HOMA-IR 水平大大低于 PGZ 和 Cr-PL 组(分别为 6.69 ± 0.11 vs. 8.37 ± 0.04、7.49 ± 0.04)。Cr-PL和Cr-GTF均可控制T2DM。与未用药的糖尿病对照组相比,两种Cr复合物对T2DM生物标志物的改善作用更大。在改变胰岛素和 HOMA-IR 血液水平方面,单用 PGZ 和 PGZ + Cr-PL 的药理协同作用不及 Cr-GTF 和 PGZ。这些令人鼓舞的发现还需要更多的研究。
{"title":"Test of insulin resistance in nondiabetic and streptozotocin-induced diabetic rats using glycosylated hemoglobin test and other interventions.","authors":"Lina AlTamimi, Zainab Z Zakaraya, Mohammad Hailat, Mousa N Ahmad, Nidal A Qinna, Mohammed F Hamad, Wael Abu Dayyih","doi":"10.4103/JAPTR.JAPTR_343_23","DOIUrl":"10.4103/JAPTR.JAPTR_343_23","url":null,"abstract":"<p><p>Type 2 diabetes is common globally. Pioglitazone (PGZ) is an oral TZD antidiabetic, whereas chromium-picolinate (Cr-PL) and Cr-glucose tolerance factor (Cr-GTF) are useful type 2 diabetes mellitus (T2DM) supplements. Cr-PL/GTF antioxidants cure T2DM. They may fail in diabetes with or without insulin-sensitizing medications. It examined how Cr-PL, Cr-GTF, PGZ, and their combination affected glucose, glycosylated hemoglobin, insulin, and HOMA-IR. Sixty-three adult Sprague-Dawley rats (220-300 g) were selected, and nine rats were randomly assigned to a normal nondiabetic group. In contrast, 54 rats were randomly split into 9 rats per each of the 6 major groups and injected intraperitoneally with 40 mg/kg STZ to induce T2DM. Rats were administered PGZ = 0.65 mg/kg (rat weight)/day, Cr-PL = 1 mg/kg, Cr-GTF = 1 mg/kg, and their combinations (PGZ + Cr-PL and Cr-GTF) daily for 6 weeks per intervention. The PGZ + Cr-PL and PGZ + Cr-GTF groups had substantially lower insulin levels than the PGZ group (13.38 ± 0.06, 12.98 ± 0.19 vs. 14.11 ± 0.02, respectively), with the PGZ + Cr-GTF group having the lowest insulin levels (12.98 ± 0.19 vs. 14.11 ± 0.02, 13.38±0.06, respectively). Intervention substantially reduced HOMA-IR in the PZ + Cr-PL and PZ + Cr-GTF groups compared to PGZ (7.49 ± 0.04, 6.69 ± 0.11 vs. 8.37 ± 0.04, respectively). This research found that combining PGZ with Cr-GTF resulted in considerably lower HOMA-IR levels than the PGZ and Cr-PL groups (6.69 ± 0.11 vs. 8.37 ± 0.04, 7.49 ± 0.04, respectively). Both Cr-PL and Cr-GTF may control T2DM. Both Cr complexes improved T2DM biomarkers more than the control diabetic group without medication. PGZ alone and PGZ + Cr-PL had less pharmacological synergy than Cr-GTF and PGZ in altering insulin and HOMA-IR blood levels. These encouraging discoveries need more study.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"15 1","pages":"1-7"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the anticancer potential of Eleutherine bulbosa: A systematic network pharmacology study on lung cancer. 探索榄香烯的抗癌潜力:一项关于肺癌的系统网络药理学研究。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.4103/JAPTR.JAPTR_334_23
Roihatul Mutiah, Ermin Rachmawati

Chemotherapy application in lung cancer patients has several side effects and shows lower effectiveness due to chemoresistance. Although Eleutherine bulbosa (Mill.) Urb. (EBE) elicit anticancer properties, yet the exact profile of its active compounds and lung cancer inhibition mechanisms were not fully understood. This study aimed to identify suggestive compounds from EBE extract and explain the molecular mechanisms of EBE against lung cancer. Identification of the compound from the EBE extract was confirmed using liquid chromatography-tandem mass spectrophotometry (LC-MS/MS). The bioavailability profile of three major metabolites was identified using absorption, distribution, metabolism, excretion, toxicity software. The anticancer molecular mechanism prediction of the drugs was ascertained by network pharmacology using Cytoscape 3.9.1 and the protein-protein interaction network technique with STRING 11.0. Interaction between resveratrol and extracellular growth factor receptor (EGFR) was analyzed using site-specific molecular docking with erlotinib as the control using PyRx Autodock Vina 9.0 and BIOVIA Discovery Studio. A total of 16 active compounds were identified from LC-MS/MS. Only resveratrol showed anticancer properties by its interaction with 13 genes and 6 signaling pathways related to lung cancer. The molecular docking result supports the network pharmacology finding. The binding affinity of resveratrol with EGFR, important receptor in lung cancer, was more negative (-6.9 kcal/mol) than erlotinib (-6.2 kcal/mol) as the control. Evidence suggested that resveratrol in EBE exhibits anticancer effects by modulating lung cancer cell proliferation and apoptosis through EGFR binding.

对肺癌患者进行化疗会产生一些副作用,而且由于化疗耐药性,化疗效果较差。虽然榄香烯(Eleutherine bulbosa (Mill.) Urb.)具有抗癌特性,但其活性化合物的确切特征和肺癌抑制机制尚未完全清楚。本研究旨在从EBE提取物中鉴定提示性化合物,并解释EBE抗肺癌的分子机制。研究采用液相色谱-串联质谱法(LC-MS/MS)确认了刺五加提取物中的化合物。利用吸收、分布、代谢、排泄、毒性软件确定了三种主要代谢物的生物利用度。利用 Cytoscape 3.9.1 的网络药理学和 STRING 11.0 的蛋白质-蛋白质相互作用网络技术确定了药物的抗癌分子机制预测。利用PyRx Autodock Vina 9.0和BIOVIA Discovery Studio,以厄洛替尼为对照,采用位点特异性分子对接分析了白藜芦醇与细胞外生长因子受体(EGFR)之间的相互作用。LC-MS/MS 共鉴定出 16 种活性化合物。只有白藜芦醇通过与肺癌相关的13个基因和6条信号通路的相互作用显示出抗癌特性。分子对接结果支持了网络药理学的发现。白藜芦醇与肺癌重要受体表皮生长因子受体的结合亲和力(-6.9 kcal/mol)比对照组厄洛替尼(-6.2 kcal/mol)更负。有证据表明,EBE 中的白藜芦醇可通过与表皮生长因子受体结合,调节肺癌细胞的增殖和凋亡,从而发挥抗癌作用。
{"title":"Exploring the anticancer potential of <i>Eleutherine bulbosa</i>: A systematic network pharmacology study on lung cancer.","authors":"Roihatul Mutiah, Ermin Rachmawati","doi":"10.4103/JAPTR.JAPTR_334_23","DOIUrl":"10.4103/JAPTR.JAPTR_334_23","url":null,"abstract":"<p><p>Chemotherapy application in lung cancer patients has several side effects and shows lower effectiveness due to chemoresistance. Although <i>Eleutherine bulbosa</i> (Mill.) Urb. (EBE) elicit anticancer properties, yet the exact profile of its active compounds and lung cancer inhibition mechanisms were not fully understood. This study aimed to identify suggestive compounds from EBE extract and explain the molecular mechanisms of EBE against lung cancer. Identification of the compound from the EBE extract was confirmed using liquid chromatography-tandem mass spectrophotometry (LC-MS/MS). The bioavailability profile of three major metabolites was identified using absorption, distribution, metabolism, excretion, toxicity software. The anticancer molecular mechanism prediction of the drugs was ascertained by network pharmacology using Cytoscape 3.9.1 and the protein-protein interaction network technique with STRING 11.0. Interaction between resveratrol and extracellular growth factor receptor (EGFR) was analyzed using site-specific molecular docking with erlotinib as the control using PyRx Autodock Vina 9.0 and BIOVIA Discovery Studio. A total of 16 active compounds were identified from LC-MS/MS. Only resveratrol showed anticancer properties by its interaction with 13 genes and 6 signaling pathways related to lung cancer. The molecular docking result supports the network pharmacology finding. The binding affinity of resveratrol with EGFR, important receptor in lung cancer, was more negative (-6.9 kcal/mol) than erlotinib (-6.2 kcal/mol) as the control. Evidence suggested that resveratrol in EBE exhibits anticancer effects by modulating lung cancer cell proliferation and apoptosis through EGFR binding.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"15 1","pages":"49-55"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139935129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stability study and development of the validated infrared spectrometric method for quantitative analysis of sevoflurane compared with the gas chromatographic method. 用于七氟醚定量分析的验证性红外光谱法与气相色谱法的稳定性研究和开发比较。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.4103/japtr.japtr_377_23
Kahtan Jassim Hasson

Sevoflurane, also called fluoromethyl ether, is an inhalation anesthetic agent used to initiate and maintain general anesthesia for adults and pediatric patients during surgical procedures. Several analytical methods have previously been applied to follow the properties and quality of sevoflurane, including mass spectrometry and gas chromatography methods. These methods are practically tedious and need sophisticated apparatus. In the present work, an attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectrometric method was used for the quantitative determination of sevoflurane which is characterized as a fast, accurate, and available technique for most pharmaceutical laboratories, besides the gas chromatographic method which is the most suitable for the detection of impurities. Sevoflurane is a liquid and it is applied directly on the glass top of the ATR-FTIR either as a concentrated solution or diluted with hexane as a diluent, which did not interfere with sample determination within the specified wavelength range of the IR spectrum, particularly the wavelength of the ethereal group at 1200 cm-1. This method can be applied to the identification test and quantitative assay of sevoflurane since it is validated for the precision, accuracy, reproducibility, and specificity in the analysis of sevoflurane as a pharmaceutical product. However, still, there is a need for a gas chromatographic method to detect the impurities and degradation products during the stability study of sevoflurane.

七氟醚(又称氟甲基醚)是一种吸入麻醉剂,用于启动和维持成人和儿童患者在手术过程中的全身麻醉。以前曾有几种分析方法用于跟踪七氟醚的特性和质量,包括质谱法和气相色谱法。这些方法实际操作起来比较繁琐,而且需要复杂的仪器。本研究采用衰减全反射-傅立叶变换红外光谱法(ATR-FTIR)对七氟烷进行定量检测,该方法快速、准确,适用于大多数制药实验室。七氟醚是一种液体,直接将其作为浓缩溶液或用正己烷稀释的稀释剂涂抹在 ATR-FTIR 的玻璃顶上,在红外光谱的指定波长范围内,尤其是 1200 cm-1 的乙醚基波长范围内,不会干扰样品的测定。该方法的精密度、准确度、重现性和特异性均得到了验证,因此可用于七氟醚的鉴定和定量检测。然而,在七氟醚的稳定性研究中,仍然需要一种气相色谱法来检测杂质和降解产物。
{"title":"Stability study and development of the validated infrared spectrometric method for quantitative analysis of sevoflurane compared with the gas chromatographic method.","authors":"Kahtan Jassim Hasson","doi":"10.4103/japtr.japtr_377_23","DOIUrl":"10.4103/japtr.japtr_377_23","url":null,"abstract":"<p><p>Sevoflurane, also called fluoromethyl ether, is an inhalation anesthetic agent used to initiate and maintain general anesthesia for adults and pediatric patients during surgical procedures. Several analytical methods have previously been applied to follow the properties and quality of sevoflurane, including mass spectrometry and gas chromatography methods. These methods are practically tedious and need sophisticated apparatus. In the present work, an attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectrometric method was used for the quantitative determination of sevoflurane which is characterized as a fast, accurate, and available technique for most pharmaceutical laboratories, besides the gas chromatographic method which is the most suitable for the detection of impurities. Sevoflurane is a liquid and it is applied directly on the glass top of the ATR-FTIR either as a concentrated solution or diluted with hexane as a diluent, which did not interfere with sample determination within the specified wavelength range of the IR spectrum, particularly the wavelength of the ethereal group at 1200 cm<sup>-1</sup>. This method can be applied to the identification test and quantitative assay of sevoflurane since it is validated for the precision, accuracy, reproducibility, and specificity in the analysis of sevoflurane as a pharmaceutical product. However, still, there is a need for a gas chromatographic method to detect the impurities and degradation products during the stability study of sevoflurane.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"15 1","pages":"19-24"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139935130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In silico analysis of luteolin derivatives as antibacterial agents targeting DNA gyrase and CTX-M-15 extended-spectrum β-lactamase of Escherichia coli. 针对大肠杆菌DNA回旋酶和CTX-M-15广谱β-内酰胺酶的木犀草素衍生物抗菌剂的硅学分析。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.4103/JAPTR.JAPTR_217_23
Nuzul Wahyuning Diyah, Dwi Ayu Indriani, Rachma Dessidianti, Siswandono Siswandono

Luteolin exhibited antibacterial activity against Escherichia coli and its chemical structure similar to that of ciprofloxacin (CPF) which works by inhibiting DNA gyrase. Filtrate from passion fruit extract containing luteolin and its derivatives could inhibit extended-spectrum β-lactamase (ESBL)-producing E. coli. Antibacterial compounds that can also inhibit ESBL will be valuable compounds to overcome the problem of resistant bacteria. This study aimed to ensure the potency of luteolin and luteolin derivatives targeting DNA gyrase and ESBL by in silico approach. Docking simulation of ligands L1-L14 was performed using AutoDock Vina, and pharmacokinetics and toxicity (absorption, distribution, metabolism, excretion, and toxicity) profiles were predicted by pKCSM online. The docking result revealed higher binding affinity on DNA gyrase (PDB.1KZN) of 12 luteolin derivatives (energy <-7.6 kcal/mol) compared to CPF and higher affinity (energy <-6.27 kcal/mol) of all compounds than clavulanic acid against ESBL CTX-M-15 (PDB.4HBU). The compounds could be absorbed through the human intestine moderately, which showed low permeability to blood-brain barrier, nontoxic and nonhepatotoxic. The most active luteolin glycoside (L6) is capable to inhibit DNA gyrase and ESBL from E. coli which provided the potential against resistant bacteria and was promoted as lead compounds to be developed further.

木犀草素对大肠杆菌具有抗菌活性,其化学结构与环丙沙星(CPF)相似,后者通过抑制 DNA 回旋酶发挥作用。含有木犀草素及其衍生物的百香果提取物滤液可抑制广谱β-内酰胺酶(ESBL)产生的大肠杆菌。同时能抑制 ESBL 的抗菌化合物将是克服耐药菌问题的重要化合物。本研究旨在通过硅学方法确保木犀草素和木犀草素衍生物针对DNA回旋酶和ESBL的有效性。利用 AutoDock Vina 对配体 L1-L14 进行了对接模拟,并利用 pKCSM 在线预测了药代动力学和毒性(吸收、分布、代谢、排泄和毒性)曲线。对接结果表明,12 种木犀草素衍生物对 DNA 回旋酶(PDB.1KZN)具有更高的结合亲和力,具有抗大肠杆菌的潜力,被作为先导化合物进一步开发。
{"title":"<i>In silico</i> analysis of luteolin derivatives as antibacterial agents targeting DNA gyrase and CTX-M-15 extended-spectrum β-lactamase of <i>Escherichia coli</i>.","authors":"Nuzul Wahyuning Diyah, Dwi Ayu Indriani, Rachma Dessidianti, Siswandono Siswandono","doi":"10.4103/JAPTR.JAPTR_217_23","DOIUrl":"10.4103/JAPTR.JAPTR_217_23","url":null,"abstract":"<p><p>Luteolin exhibited antibacterial activity against <i>Escherichia coli</i> and its chemical structure similar to that of ciprofloxacin (CPF) which works by inhibiting DNA gyrase. Filtrate from passion fruit extract containing luteolin and its derivatives could inhibit extended-spectrum β-lactamase (ESBL)-producing <i>E</i>. <i>coli</i>. Antibacterial compounds that can also inhibit ESBL will be valuable compounds to overcome the problem of resistant bacteria. This study aimed to ensure the potency of luteolin and luteolin derivatives targeting DNA gyrase and ESBL by <i>in silico</i> approach. Docking simulation of ligands L1-L14 was performed using AutoDock Vina, and pharmacokinetics and toxicity (absorption, distribution, metabolism, excretion, and toxicity) profiles were predicted by pKCSM online. The docking result revealed higher binding affinity on DNA gyrase (PDB.1KZN) of 12 luteolin derivatives (energy <-7.6 kcal/mol) compared to CPF and higher affinity (energy <-6.27 kcal/mol) of all compounds than clavulanic acid against ESBL CTX-M-15 (PDB.4HBU). The compounds could be absorbed through the human intestine moderately, which showed low permeability to blood-brain barrier, nontoxic and nonhepatotoxic. The most active luteolin glycoside (L6) is capable to inhibit DNA gyrase and ESBL from <i>E. coli</i> which provided the potential against resistant bacteria and was promoted as lead compounds to be developed further.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"15 1","pages":"29-36"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the modulation of MLH1 and MSH2 gene expression in hesperetin-treated breast cancer cells (BT-474). 探索七叶皂苷(hesperetin)处理的乳腺癌细胞(BT-474)中 MLH1 和 MSH2 基因表达的调节。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.4103/japtr.japtr_279_23
Ahmed Mohammed Salman, Esmaeil Babaei, Ahmed Salim Kadhim Al-Khafaji

The major mortality factor for women globally is breast cancer, and current treatments have several adverse effects. Hesperetin (HSP) is a flavone that occurs naturally with anti-tumor capabilities and has been investigated as a potential treatment for cancer. This study aimed to investigate the cytotoxic and anti-malignant potential of HSP on breast cancer cells (BT-474) and normal cells (MCF-10a). The results indicated that HSP has dose-dependent cytotoxicity in BT-474 and MCF-10a cells. The elevated concentration of HSP lowered cell viability and proliferation. The half-maximal inhibitory concentration (IC50) of HSP in BT-474 cancer cells after a 48-h exposure was 279.2 μM/ml, while the IC50 in normal cells was 855.4 μM/ml. The cytotoxicity of HSP was more significant in cancer cell lines than in normal cell lines and this aspect presents a favorable factor in utilizing the drug for the treatment of breast cancer. The apoptotic effect of HSP in BT-474 cells was investigated, and it was found that the higher the concentration of HSP more the cells underwent apoptosis. Furthermore, the highest concentration of HSP led to overexpression of the MLH1 and MSH2 genes in both breast cancer and normal cell lines. Overall, our study suggests that HSP has an anticancer effect on breast cancer cell lines, and the effect is concentration dependent.

全球妇女的主要死亡因素是乳腺癌,而目前的治疗方法有多种不良影响。橙皮素(Hesperetin,HSP)是一种天然黄酮,具有抗肿瘤能力,已被研究作为一种潜在的癌症治疗方法。本研究旨在探讨 HSP 对乳腺癌细胞(BT-474)和正常细胞(MCF-10a)的细胞毒性和抗恶性潜能。结果表明,HSP 对 BT-474 和 MCF-10a 细胞具有剂量依赖性细胞毒性。HSP 浓度升高会降低细胞活力和增殖。暴露 48 小时后,HSP 在 BT-474 癌细胞中的半最大抑制浓度(IC50)为 279.2 μM/ml,而在正常细胞中的 IC50 为 855.4 μM/ml。与正常细胞株相比,HSP 在癌细胞株中的细胞毒性更为显著,这为利用该药物治疗乳腺癌提供了有利条件。研究了 HSP 对 BT-474 细胞的凋亡效应,发现 HSP 浓度越高,细胞凋亡越多。此外,最高浓度的 HSP 会导致乳腺癌细胞株和正常细胞株中的 MLH1 和 MSH2 基因过度表达。总之,我们的研究表明,HSP 对乳腺癌细胞株有抗癌作用,而且这种作用与浓度有关。
{"title":"Exploring the modulation of MLH1 and MSH2 gene expression in hesperetin-treated breast cancer cells (BT-474).","authors":"Ahmed Mohammed Salman, Esmaeil Babaei, Ahmed Salim Kadhim Al-Khafaji","doi":"10.4103/japtr.japtr_279_23","DOIUrl":"10.4103/japtr.japtr_279_23","url":null,"abstract":"<p><p>The major mortality factor for women globally is breast cancer, and current treatments have several adverse effects. Hesperetin (HSP) is a flavone that occurs naturally with anti-tumor capabilities and has been investigated as a potential treatment for cancer. This study aimed to investigate the cytotoxic and anti-malignant potential of HSP on breast cancer cells (BT-474) and normal cells (MCF-10a). The results indicated that HSP has dose-dependent cytotoxicity in BT-474 and MCF-10a cells. The elevated concentration of HSP lowered cell viability and proliferation. The half-maximal inhibitory concentration (IC<sub>50</sub>) of HSP in BT-474 cancer cells after a 48-h exposure was 279.2 μM/ml, while the IC<sub>50</sub> in normal cells was 855.4 μM/ml. The cytotoxicity of HSP was more significant in cancer cell lines than in normal cell lines and this aspect presents a favorable factor in utilizing the drug for the treatment of breast cancer. The apoptotic effect of HSP in BT-474 cells was investigated, and it was found that the higher the concentration of HSP more the cells underwent apoptosis. Furthermore, the highest concentration of HSP led to overexpression of the MLH1 and MSH2 genes in both breast cancer and normal cell lines. Overall, our study suggests that HSP has an anticancer effect on breast cancer cell lines, and the effect is concentration dependent.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"15 1","pages":"43-48"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of Lactobacillus casei probiotic microparticles in L-type methacrylic acid copolymer matrix. L 型甲基丙烯酸共聚物基质中的干酪乳杆菌益生菌微颗粒的特性。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.4103/JAPTR.JAPTR_267_23
Sugiyartono, Widji Soeratri, Arini Permatasari, Ayun Dewi Rahayu, Dwi Setyawan, Dewi Isadiartuti

Lactobacillus casei (LC) is a type of lactic acid bacterium that is known for its beneficial probiotic properties. However, it is not typically found in the human intestine because it lacks acid resistance. LC thrives in an optimal pH environment of 6.8 and can be initiated in a more acidic environment at a pH of 3.5. This study purposed to compare the effect of L-type methacrylic acid copolymer (MAC) as a matrix (0.50%, 0.75%, and 1.00%) on the physical characteristics of LC probiotic microparticles made by the spray drying process. Probiotic microparticles were also made from a dry suspension of LC FNCC 0090 bacteria and dispersed in a solution of L-type MAC. The results showed that a rise in matrix content by 1.00% increased particle size (4.47 ± 0.19 µm) and reduced moisture content (7.45 ± 0.11%). The analysis of microparticle morphology also indicated a positive correlation between the level of L-type MAC and the production of smooth, nonporous, and almost spherical shapes. In addition, it was observed that encapsulation efficiency (92.46 ± 0.17%) and protection against stomach acid (98.17% ±1.17%) increased with the level of the matrix.

干酪乳杆菌(LC)是一种乳酸菌,因其有益的益生特性而闻名。然而,由于缺乏耐酸性,人类肠道中通常找不到这种细菌。乳酸菌在最佳 pH 值为 6.8 的环境中茁壮成长,并可在 pH 值为 3.5 的较酸性环境中开始生长。本研究旨在比较以 L 型甲基丙烯酸共聚物(MAC)为基质(0.50%、0.75% 和 1.00%)对喷雾干燥工艺制作的 LC 益生菌微颗粒物理特性的影响。益生菌微颗粒也是由 LC FNCC 0090 细菌的干悬浮液制成,并分散在 L 型 MAC 溶液中。结果表明,基质含量增加 1.00%,颗粒尺寸(4.47 ± 0.19 µm)增大,水分含量(7.45 ± 0.11%)降低。对微粒形态的分析还表明,L 型 MAC 的含量与产生光滑、无孔和近似球形的微粒之间存在正相关。此外,还观察到封装效率(92.46 ± 0.17%)和对胃酸的保护(98.17% ± 1.17%)随着基质水平的提高而增加。
{"title":"Characteristics of <i>Lactobacillus casei</i> probiotic microparticles in L-type methacrylic acid copolymer matrix.","authors":"Sugiyartono, Widji Soeratri, Arini Permatasari, Ayun Dewi Rahayu, Dwi Setyawan, Dewi Isadiartuti","doi":"10.4103/JAPTR.JAPTR_267_23","DOIUrl":"10.4103/JAPTR.JAPTR_267_23","url":null,"abstract":"<p><p><i>Lactobacillus casei</i> (LC) is a type of lactic acid bacterium that is known for its beneficial probiotic properties. However, it is not typically found in the human intestine because it lacks acid resistance. LC thrives in an optimal pH environment of 6.8 and can be initiated in a more acidic environment at a pH of 3.5. This study purposed to compare the effect of L-type methacrylic acid copolymer (MAC) as a matrix (0.50%, 0.75%, and 1.00%) on the physical characteristics of LC probiotic microparticles made by the spray drying process. Probiotic microparticles were also made from a dry suspension of LC FNCC 0090 bacteria and dispersed in a solution of L-type MAC. The results showed that a rise in matrix content by 1.00% increased particle size (4.47 ± 0.19 µm) and reduced moisture content (7.45 ± 0.11%). The analysis of microparticle morphology also indicated a positive correlation between the level of L-type MAC and the production of smooth, nonporous, and almost spherical shapes. In addition, it was observed that encapsulation efficiency (92.46 ± 0.17%) and protection against stomach acid (98.17% ±1.17%) increased with the level of the matrix.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"15 1","pages":"37-42"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Garcinia dulcis and Garcinia forbesii King fruit peel extract: Secondary metabolite composition, antioxidant, and elastase inhibitory activity evaluation. 杜仲和福王果皮提取物:次生代谢物成分、抗氧化剂和弹性蛋白酶抑制活性评价。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.4103/japtr.japtr_344_23
Neneng Siti Silfi Ambarwati, Nurnisya Tiara Sukma, Yesi Desmiaty, Annisa Auliya, Setia Budi, M Arifuddin, Islamudin Ahmad

Garcinia dulcis and Garcinia forbesii King are native plants from Indonesia and have tremendous potential as a source of raw medicines based on local wisdom. However, scientific data for strengthening pharmaceuticals are still limited. Therefore, it is necessary to conduct a study to strengthen and develop the potential of both plants using the approach of traditional medicine. This study aimed to explore the secondary metabolite composition and biological activity (antioxidant and antielastase) of both plants. Both samples were extracted using 70% ethanol and microwave-assisted extraction with a microwave power of 120 watts for 15 min. The extract obtained was then screened for phytochemicals using specific reagents. The total phenolic content (TPC) was determined using spectrophotometry with a 96-well microplate reader method. The total flavonoid content (TFC) was determined using the colorimetric method, whereas metabolite profiling analysis was conducted using the UPLC-QToF-MS/MS system. Meanwhile, biological activity was tested for antioxidant activity and antielastase as measured by a microplate reader 96-well spectrophotometry method at specific wavelengths. According to the results, G. dulcis and G. forbesii fruit peel extracts showed positive detection of particular secondary metabolites. TPC and TFC values were 13.98 ± 1.90 mg GAE/g and 10.33 ± 1.90 mg QE/g for G. dulcis and 11.98 ± 2.04 mgGAE/g and 1.96 ± 0.36 mgQE/g for G. forbesii. Metabolite profiling detected some compounds from G. dulcis, including ephedrannin B, hinokiflavone, mahuannin J, and candidate mass C9H12O8, and G. forbesii, including 5-Hydroxy-7,8,2'- trimethoxyflavone, lucialdehyde B, candidate mass C21H39NO4, candidate mass C14H10O6, and candidate mass C14H12O6. Meanwhile, the biological activities (antioxidant and antielastase) were 137.721 μg/mL and 108.893 μg/mL for G. dulcis and 481.948 μg/mL and 250.611 μg/mL for G. forbesii, respectively. Both plants showed different profiles of secondary metabolites and biological activities (antioxidant and antielastase) according to their respective characteristics.

Garcinia dulcis 和 Garcinia forbesii King 是印度尼西亚的原生植物,作为基于当地智慧的原药来源具有巨大的潜力。然而,用于强化制药的科学数据仍然有限。因此,有必要开展一项研究,利用传统医学方法加强和开发这两种植物的潜力。本研究旨在探索这两种植物的次生代谢物成分和生物活性(抗氧化和抗弹性蛋白酶)。两种样本均使用 70% 的乙醇提取,并在 120 瓦的微波功率下进行 15 分钟的微波辅助提取。然后使用特定试剂对提取物进行植物化学成分筛选。总酚含量(TPC)采用分光光度法和 96 孔微孔板阅读器法进行测定。总黄酮含量(TFC)采用比色法测定,代谢物谱分析采用 UPLC-QToF-MS/MS 系统进行。同时,利用微板阅读器 96 孔分光光度法在特定波长下测定了抗氧化活性和抗弹性蛋白酶的生物活性。结果表明,G. dulcis 和 G. forbesii 果皮提取物对特定次生代谢物的检测呈阳性。G. dulcis 的 TPC 和 TFC 值分别为 13.98 ± 1.90 mg GAE/g 和 10.33 ± 1.90 mg QE/g,G. forbesii 的 TPC 和 TFC 值分别为 11.98 ± 2.04 mgGAE/g 和 1.96 ± 0.36 mgQE/g。代谢物分析检测到一些来自枳壳的化合物,包括麻黄素 B、桧黄酮、麻黄素 J 和候选质量 C9H12O8,以及福寿果的化合物,包括 5-羟基-7,8,2'-三甲氧基黄酮、苜蓿醛 B、候选质量 C21H39NO4、候选质量 C14H10O6 和候选质量 C14H12O6。同时,G. dulcis 和 G. forbesii 的生物活性(抗氧化和抗弹性蛋白酶)分别为 137.721 μg/mL 和 108.893 μg/mL,G. forbesii 为 481.948 μg/mL 和 250.611 μg/mL。这两种植物根据各自的特点,表现出了不同的次生代谢物特征和生物活性(抗氧化和抗弹性蛋白酶)。
{"title":"<i>Garcinia dulcis</i> and <i>Garcinia forbesii</i> King fruit peel extract: Secondary metabolite composition, antioxidant, and elastase inhibitory activity evaluation.","authors":"Neneng Siti Silfi Ambarwati, Nurnisya Tiara Sukma, Yesi Desmiaty, Annisa Auliya, Setia Budi, M Arifuddin, Islamudin Ahmad","doi":"10.4103/japtr.japtr_344_23","DOIUrl":"10.4103/japtr.japtr_344_23","url":null,"abstract":"<p><p><i>Garcinia dulcis</i> and <i>Garcinia forbesii</i> King are native plants from Indonesia and have tremendous potential as a source of raw medicines based on local wisdom. However, scientific data for strengthening pharmaceuticals are still limited. Therefore, it is necessary to conduct a study to strengthen and develop the potential of both plants using the approach of traditional medicine. This study aimed to explore the secondary metabolite composition and biological activity (antioxidant and antielastase) of both plants. Both samples were extracted using 70% ethanol and microwave-assisted extraction with a microwave power of 120 watts for 15 min. The extract obtained was then screened for phytochemicals using specific reagents. The total phenolic content (TPC) was determined using spectrophotometry with a 96-well microplate reader method. The total flavonoid content (TFC) was determined using the colorimetric method, whereas metabolite profiling analysis was conducted using the UPLC-QToF-MS/MS system. Meanwhile, biological activity was tested for antioxidant activity and antielastase as measured by a microplate reader 96-well spectrophotometry method at specific wavelengths. According to the results, <i>G. dulcis</i> and <i>G. forbesii</i> fruit peel extracts showed positive detection of particular secondary metabolites. TPC and TFC values were 13.98 ± 1.90 mg GAE/g and 10.33 ± 1.90 mg QE/g for <i>G. dulcis</i> and 11.98 ± 2.04 mgGAE/g and 1.96 ± 0.36 mgQE/g for <i>G. forbesii</i>. Metabolite profiling detected some compounds from <i>G. dulcis</i>, including ephedrannin B, hinokiflavone, mahuannin J, and candidate mass C<sub>9</sub>H<sub>12</sub>O<sub>8</sub>, and <i>G. forbesii</i>, including 5-Hydroxy-7,8,2'- trimethoxyflavone, lucialdehyde B, candidate mass C<sub>21</sub>H<sub>39</sub>NO<sub>4</sub>, candidate mass C<sub>14</sub>H<sub>10</sub>O<sub>6</sub>, and candidate mass C<sub>14</sub>H<sub>12</sub>O<sub>6</sub>. Meanwhile, the biological activities (antioxidant and antielastase) were 137.721 μg/mL and 108.893 μg/mL for <i>G. dulcis</i> and 481.948 μg/mL and 250.611 μg/mL for <i>G. forbesii</i>, respectively. Both plants showed different profiles of secondary metabolites and biological activities (antioxidant and antielastase) according to their respective characteristics.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"15 1","pages":"8-12"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The interaction of Suk-Saiyasna remedy with GABAA and CB1 receptor-targeting drugs: Enhancing hypnotic and sedative effects in in vivo models. Suk-Saiyasna 药方与 GABAA 和 CB1 受体靶向药物的相互作用:增强体内模型的催眠和镇静效果。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.4103/JAPTR.JAPTR_355_23
Watchara Damjuti, Worathat Thitikornpong, Sinsamut Saengow, Thanundorn Thanusuwannasak, Thanes Fuangfoo, Jurairat Boonruab

The Suk-Saiyasna remedy, an herbal treatment, was historically used but ceased due to its cannabis content. After a relaxation of drug control laws in Thailand, its use re-emerged. This study examines the Suk-Saiyasna remedy's impact on rodent behavior and its receptor effects. This study was conducted to assess the sedative-like effects of the remedy on mice. The mice were divided into groups receiving 0.6, 3, 30, and 60 mg/kg extracts, with negative controls for comparison. We also investigated the impact on receptors, utilizing negative controls and pretreatment with receptor blockers, followed by either a negative control or a 60 mg/kg extract. Furthermore, this study investigated the behavioral aspects of mice, including anxiolytic effects, antidepressant-like effects, and motor coordination, utilizing the elevated plus-maze, open-field, and rotarod performance tests. The Suk-Saiyasna remedy (P < 0.05) decreased significantly in the latent period and increased sleeping time in the treated groups. Moreover, the Suk-Saiyasna remedy also showed efficacy in reaction to GABAA receptors and cannabinoid CB1 receptors (P < 0.05). In addition, positive effects were observed regarding the animal behavior in the arena, as the animal activity, behavior, and muscle coordination were reduced (P < 0.05). The Suk-Saiyasna remedy may be involved in a sedative-hypnotic-like effect in rodents under normal conditions through the modulation of GABAergic neurons and induction of the cannabinoid CB1 receptor mechanism.

Suk-Saiyasna 药方是一种草药疗法,历史上曾被使用过,但由于含有大麻而停止使用。在泰国放宽药物管制法之后,这种草药的使用重新兴起。本研究探讨了 Suk-Saiyasna 药方对啮齿动物行为的影响及其受体效应。本研究旨在评估该药对小鼠的镇静作用。小鼠被分为接受 0.6、3、30 和 60 毫克/千克提取物的组别,并与阴性对照组进行比较。我们还利用阴性对照组和受体阻断剂预处理组,以及阴性对照组或 60 毫克/千克提取物组,研究了对受体的影响。此外,本研究还利用高架迷宫、开阔地和旋转木马性能测试,对小鼠的行为方面进行了调查,包括抗焦虑作用、抗抑郁样作用和运动协调性。Suk-Saiyasna疗法(P < 0.05)显著减少了治疗组的潜伏期,增加了睡眠时间。此外,Suk-Saiyasna疗法对GABAA受体和大麻素CB1受体的反应也有疗效(P < 0.05)。此外,在竞技场中动物的行为方面也观察到了积极的效果,动物的活动、行为和肌肉协调性都有所降低(P < 0.05)。在正常情况下,Suk-Saiyasna 药方可能通过调节 GABA 能神经元和诱导大麻素 CB1 受体机制,对啮齿类动物产生类似镇静催眠的效果。
{"title":"The interaction of Suk-Saiyasna remedy with GABAA and CB1 receptor-targeting drugs: Enhancing hypnotic and sedative effects in <i>in vivo</i> models.","authors":"Watchara Damjuti, Worathat Thitikornpong, Sinsamut Saengow, Thanundorn Thanusuwannasak, Thanes Fuangfoo, Jurairat Boonruab","doi":"10.4103/JAPTR.JAPTR_355_23","DOIUrl":"10.4103/JAPTR.JAPTR_355_23","url":null,"abstract":"<p><p>The Suk-Saiyasna remedy, an herbal treatment, was historically used but ceased due to its cannabis content. After a relaxation of drug control laws in Thailand, its use re-emerged. This study examines the Suk-Saiyasna remedy's impact on rodent behavior and its receptor effects. This study was conducted to assess the sedative-like effects of the remedy on mice. The mice were divided into groups receiving 0.6, 3, 30, and 60 mg/kg extracts, with negative controls for comparison. We also investigated the impact on receptors, utilizing negative controls and pretreatment with receptor blockers, followed by either a negative control or a 60 mg/kg extract. Furthermore, this study investigated the behavioral aspects of mice, including anxiolytic effects, antidepressant-like effects, and motor coordination, utilizing the elevated plus-maze, open-field, and rotarod performance tests. The Suk-Saiyasna remedy (<i>P</i> < 0.05) decreased significantly in the latent period and increased sleeping time in the treated groups. Moreover, the Suk-Saiyasna remedy also showed efficacy in reaction to GABAA receptors and cannabinoid CB1 receptors (<i>P</i> < 0.05). In addition, positive effects were observed regarding the animal behavior in the arena, as the animal activity, behavior, and muscle coordination were reduced (<i>P</i> < 0.05). The Suk-Saiyasna remedy may be involved in a sedative-hypnotic-like effect in rodents under normal conditions through the modulation of GABAergic neurons and induction of the cannabinoid CB1 receptor mechanism.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"15 1","pages":"13-18"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880918/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of antiaging cream with Oxalis dehradunensis R. ethanolic extract as skin aging care among woman agriculture workers. 用 Oxalis dehradunensis R.乙醇提取物制成的抗衰老霜对农业女工皮肤老化护理的功效。
IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI: 10.4103/japtr.Japtr_388_23
Eka Lestari Mahyuni, Urip Harahap

Skin damage and aging are potential health problems for woman agriculture workers. This study aimed to test the efficacy of Oxalis dehradunensis ethanol extract formulated in antiaging cream preparations as an aging treatment in women agriculture workers. The method carried out was an experimental study on woman agriculture workers who were willing to volunteer. The experimental scenario conducted related to the physical quality of antiaging cream products and the efficacy of creams on the skin as an antiaging treatment. Physical quality parameters of antiaging cream include organoleptic assessment, cream emulsion, homogeneity, viscosity, pH, distribution, and skin irritation test to evaluate potential side effects. Skin aging efficacy assessments were conducted on 12 subjects divided into four formula concentration groups. The physical skin identification parameters measured are moisture, pore size, pigmentation or spots, and wrinkles using a skin analyzer. The results found that O. dehradunensis leaf extract formulated as an antiaging cream can neutralize free radicals and is an effective countermeasure against premature skin aging. There were significant differences in the skin characteristics of woman agriculture workers who participated as samples. The formula with 5% concentrate and 7% extract of O. dehradunensis has provided a reaction and is more effective in continuous treatment. It provides skin moisture changes of more than 300%, disguises pore size and good pigmentation, and reduces wrinkles of farmers who are constantly exposed to chemicals and free radicals in their agricultural activities. The leaf extracts antiaging cream showed more significant changes in moisture and skin pigmentation. It was concluded that the use of O. dehradunensis leaf extract as the core ingredient of antiaging cream can be an innovation that is beneficial to the health of the farming community, especially among women agriculture workers.

皮肤损伤和衰老是农业女工潜在的健康问题。本研究旨在测试将 Oxalis dehradunensis 乙醇提取物配制成抗衰老霜制剂作为农业女工衰老治疗剂的功效。研究方法是对自愿参加的农业女工进行实验研究。实验情景涉及抗衰老面霜产品的物理质量和面霜作为抗衰老治疗对皮肤的功效。抗衰老面霜的物理质量参数包括感官评估、面霜乳液、均匀度、粘度、pH 值、分布和皮肤刺激测试,以评估潜在的副作用。对 12 名受试者进行了皮肤老化功效评估,分为四个配方浓度组。使用皮肤分析仪测量的皮肤物理识别参数包括水分、毛孔大小、色素沉着或斑点以及皱纹。结果发现,O. dehradunensis 叶提取物配制成的抗衰老霜可以中和自由基,是防止皮肤过早衰老的有效对策。作为样本的农业女工的皮肤特征存在明显差异。含有 5%浓缩物和 7%O.dehradunensis提取物的配方产生了反应,在持续治疗中更为有效。它能使皮肤水分变化超过 300%,掩盖毛孔粗大和良好的色素沉着,并减少在农业活动中经常接触化学品和自由基的农民的皱纹。叶提取物抗衰老霜在水分和皮肤色素沉着方面的变化更为显著。研究得出结论,使用 O. dehradunensis 叶提取物作为抗衰老霜的核心成分是一种创新,有益于农民群体的健康,尤其是女性农业工人的健康。
{"title":"The efficacy of antiaging cream with <i>Oxalis dehradunensis</i> R. ethanolic extract as skin aging care among woman agriculture workers.","authors":"Eka Lestari Mahyuni, Urip Harahap","doi":"10.4103/japtr.Japtr_388_23","DOIUrl":"10.4103/japtr.Japtr_388_23","url":null,"abstract":"<p><p>Skin damage and aging are potential health problems for woman agriculture workers. This study aimed to test the efficacy of <i>Oxalis dehradunensis</i> ethanol extract formulated in antiaging cream preparations as an aging treatment in women agriculture workers. The method carried out was an experimental study on woman agriculture workers who were willing to volunteer. The experimental scenario conducted related to the physical quality of antiaging cream products and the efficacy of creams on the skin as an antiaging treatment. Physical quality parameters of antiaging cream include organoleptic assessment, cream emulsion, homogeneity, viscosity, pH, distribution, and skin irritation test to evaluate potential side effects. Skin aging efficacy assessments were conducted on 12 subjects divided into four formula concentration groups. The physical skin identification parameters measured are moisture, pore size, pigmentation or spots, and wrinkles using a skin analyzer. The results found that <i>O. dehradunensis</i> leaf extract formulated as an antiaging cream can neutralize free radicals and is an effective countermeasure against premature skin aging. There were significant differences in the skin characteristics of woman agriculture workers who participated as samples. The formula with 5% concentrate and 7% extract of <i>O. dehradunensis</i> has provided a reaction and is more effective in continuous treatment. It provides skin moisture changes of more than 300%, disguises pore size and good pigmentation, and reduces wrinkles of farmers who are constantly exposed to chemicals and free radicals in their agricultural activities. The leaf extracts antiaging cream showed more significant changes in moisture and skin pigmentation. It was concluded that the use of <i>O. dehradunensis</i> leaf extract as the core ingredient of antiaging cream can be an innovation that is beneficial to the health of the farming community, especially among women agriculture workers.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"15 1","pages":"56-61"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Advanced Pharmaceutical Technology & Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1